The E2F family of transcription factors consists of two subgroups termed E2F and DP. E2F is required for cell proliferation, and is necessary for fruit fly development. E2F activity is a target for regulation by the retinoblastoma gene family, which includes pRB, ~107 and ~130. Mutant RB-'-, RB-'-:pl07" and p107":p130-'-mice develop abnormally, probably as a result of dysregulation in the activity of E2F, indicating the importance of E2F in mammalian development. To investigate the role of E2F in murine development, we have examined the patterns of expression of E2F-1 through E2F-5, and DP-1 in the developing nervous system by in situ hybridization. E2F-1, E2F-2 and E2F-5 are first detected in the 9.5 days post-coitus (dpc) forebrain. Expression of these E2F forms extends caudally thereafter and includes the developing brain and the upper half of the 10.5 dpc spinal cord. By 11.5 dpc, these E2F factors are expressed throughout the central nervous system. In 12.5 dpc embryos, E2F-1, E2F-2 and E2F-5 are highly expressed in proliferating, undifferentiated neuronal precursors. As neurons differentiate and migrate to the outer marginal zones in the nervous system, expression of these E2F members is extinguished. In the developing retina, another neuronal tissue, E2F-1 expression is also confined to the proliferating, undifferentiated retinoblastic layer. In contrast, E2F-3 expression is up-regulated as retinoblasts differentiate into the ganglion cell layer. In non-neuronal tissues, high E2F-4 transcript levels are present in regions corresponding to proliferative chondrocytes, whereas E2F-2 and E2F-4 transcripts are very abundant in the thymic cortex, which contains immature thymocytes. We conclude that individual E2F forms are differentially regulated during the development of distinct tissues, and especially during neuronal development. 0 1997 Elsevier Science Ireland Ltd.
Introduction
The products of the retinoblastoma-related gene family include pRl3, ~107 and ~130 (Harmon et al., 1993; Mayo1 et al., 1993; Baldi et al., 1995) . These factors are components of an important network that controls cell proliferation. In this network, appropriate regulation and interactions of cyclins, cyclin-dependent kinases and their inhibitors, pRB family proteins and E2F factors ensure normal transit through the cell cycle. pRB was one of the first tumor suppressor proteins to be identified. In humans, inactivation of both pRB alleles gives rise to retinoblastoma.
Other human malignancies frequently exhibit alterations that inactivate the pRB growth pathway, consistent with the concept that its deregulation is an important step in tumorigenesis. In addition, a role for pRB as a regulator in development is evidenced by the abnormalities in RB-/-mouse embryos and their failure to progress beyond 14-15 days of gestation (Clarke et al., 1992; . The RB-/-phenotype is exacerbated by the additional loss of ~107 in RB-/-: p107" mutant embryos (Lee et al., 1996) . This suggests that ~107 also plays a role during development, even though ~107~'-single mutants develop normally (Lee et al., 1996) .
The pRB family of proteins associates with and modulates the transcriptional activity of E2F (Cao et al.. 1992; Devoto et al., 1992; Lees et al., 1992; Shirodkar et al.. 1992; Cobrinik, 1993) . Only two E2F members termed dE2F and 1993; Ivey-Hoyle et al., 1993; Lees et al., 1993; Beijersber- temporal regulation of E2F expression, including specific gen et Ginsberg et al., 1994; Sardet et al., 1995) .
expression of E2F-1, E2F-2 and E2F-5 transcripts in prolifThe active complexes consist of heterodimers containing erating nervous tissue. These observations indicate that one E2F and one DP form Helin et mechanisms regulating E2F expression may play an imporal., 1993; Helin and Harlow, 1994; Wu et al., 1995) .
tant role in the development of nervous tissues such as brain Recently, it has become apparent that E2F has multiple and retina. The expression patterns of E2F-5 transcripts in functions. Whereas free E2F-DP complexes can transactinervous tissues contrast with those observed in epithelial vate promoters of genes necessary for proliferation (Wade tissues , in which E2F-5 expression is up-regulated in differet al., 1992; Ishii et al., 1993; Kirch et al., 1993; Ogris et al., entiating cells (Dagnino et al., 1997) . Together, our obser-1993; Oswald et al., 1994; &hilling and Famham, 1994;  vations provide evidence for tissue-specific and Chen et al., 1995; Schulze et al., 1995) , E2F-DP dimers developmental stage-specific mechanisms that modulate associated with a pRB family member can repress transcrip-E2F expression.
1 tion from those same promoters. For this reason, E2F can either promote or inhibit cell proliferation and transformation, depending on its association with other factors. For example, E2F-1 and E2F-4 are oncogenic when overexpressed in cultured fibroblasts (Beijersbergen et al., 1994; Johnson et al., 1994a; Adams and Kaelin, 1996) . In contrast, E2F-I-/-mutant mice develop a variety of tumors, conceivably due at least in part, to the loss of E2F-1 growth suppressor activity (Beijersbergen et al., 1994; Adams and Kaelin, 1996) .
Results

Isolation of a partial mouse E2F-3 cDNA
Other observations also indicate the importance of E2F for normal development. Inactivation of dE2F in the fruit fly is lethal, and mutant embryos fail to progress beyond nuclear cycle 17 (Duronio et al., 1995) . The loss of dE2F function in the eye imaginal disc also interferes with eye development (Brook et al., 1996) . E2F likely mediates important developmental processes in mammals too, although functional redundance among the five forms may occur as a consequence of inactivating a single E2F. This may explain the normal development observed in E2F-l-'-mutant mice. Nevertheless, since E2F is a primary target for pRB, ~107 and ~130, aberrant regulation of E2F likely mediates some of the developmental defects observed in RB-'-, RB-'-:pl07" and p107":p130-'-mutant embryos. Although the activity and properties of E2F have been extensively characterized in cultured cells, little is known about E2F function and expression in vivo. It has been shown that the levels of mouse E2F-1 expression during the perinatal period are higher than during adulthood (Tevosian et al., 1996) . However, there is no information about the patterns of expression of the other E2F forms during development. Because modulation of E2F activity in vivo is likely achieved by multiple mechanisms, including tissuespecific and developmental stage-specific expression, as well as post-translational regulation, it is important to identify the patterns of expression of the various E2F forms. Given that at least three of the E2F members contain functionally important E2F-binding sites in their promoters (Hsiao et al., 1994; Johnson et al., 1994b; Sears and Nevins, 1995) , mutual regulation or autoregulation is likely.
Screening of a 3T3 fibroblast cDNA library with a probe containing human E2F-3 sequences from positions 730 to 1479 yielded three partially overlapping positive clones (Fig. 1A) . The longest of these cDNA fragments, termed mE2F3B1, contained a 1525-bp insert encoding sequences homologous to those of human E2F-3 positions 328-1853 (Lees et al., 1993) (Fig. lA,B) . The identity of this clone was verified by comparing its sequence with those of other known E2F factors. Sequence analysis revealed 96% amino acid identity with human E2F-3, and no more than 57% with other mouse or human E2F members (Fig. 1C ).
E2F expression during mouse development
To better understand the roles of E2F during development, we have investigated the patterns of expression of DP-1 and E2F-1 through E2F-5 during mouse organogenesis by in situ hybridization.
We demonstrate spatial and
We examined the patterns of expression of all five E2F forms and DP-1 during mouse organogenesis in 8.5-19.5 dpc embryos. We designed probes specific for each E2F form which are schematically shown in Fig. 2 . To ensure specificity, we chose either sequences corresponding to 3'-untranslated regions, or to protein domains poorly conserved among the different E2F forms. The only exception is the partial mouse E2F-2 cDNA that we isolated, which includes the DNA-binding domain of this protein. This probe hybridized exclusively to a >7-kb transcript in Northern blot analyses (Dagnino et al., 1997) , which corresponds to the correct size of the E2F-2 mRNA. We have also compared the sequences of each of our probes with those available in the public gene databases, and confirmed that they only have substantial homology with their gene of origin. Further, we have observed non-overlapping patterns of expression of E2F-1, E2F-2 and E2F-5 in thymus (see below) and epithelial tissues (Dagnino et al., 1997) , indicating that the coincident expression of these three E2F forms in undifferentiated neuronal precursors (see below) is not artifactual. We also noted differential expression of each E2F form in retina and mesodermal tissue (see below). Together, these observations provide evidence of the specificity of the probes used in this study. ) obtained from a 3T3-fibroblast library screen with a human E2F-3 cDNA probe. Numbers designated to the mouse E2F-3 nucleotides are based on comparison of the sequence with that of the human E2F-3 cDNA. The mouse E2F3 probe used in these studies (*mEZF3 probe) contains only the 3'-untranslated region sequence subcloned from the mE2F3Cl cDNA fragment. (B) Amino acid identity between the mouse E2F-3 cDNA cloned and other mouse and human E2F forms identified to date. (C) Best-fit alignment of mouse and human E2F-3 amino acid sequences using the Needlemar-Wunsch algorithm. Amino acids are numbered at the left and right. Identity is indicated by vertical dashes, and similarity is shown by single or double dots.
Expression of E2F genes in the central and peripheral nervous systems
The expression patterns of the five E2F genes and DP-1 in the developing nervous system are summarized in Table 1. E2F-1 transcripts are just above background throughout the 8.5 dpc embryo (data not shown), and increase in the neural tube in 9.5 dpc embryos (Fig. 3A,B) . By 10.5 days of gesta- tion, E2F-1 expression increases throughout the brain, although the highest levels of expression are observed in the hindbrain (Fig. 3C ). In the 10.5 dpc spinal cord, E2F-1 is expressed only in the rostra1 half (Fig. 3C) , and by 11.5 days of gestation, E2F-1 transcripts are found throughout the brain and the spinal cord.
At 12.5 days of gestation, some neuronal precursors have started to differentiate and migrate, giving rise to the ventricular, intermediate and marginal zones in the neopallial cortex and in the diencephalon. At this stage, the undifferentiated, proliferating neuronal precursors localize to the ventricular region, whereas post-mitotic differentiating neurons migrate to form the intermediate and marginal areas. In the 12.5-16.5 dpc nervous system, E2F-1 is expressed in ventricular regions throughout the brain, but not in intermediate or marginal zones. E2F-1 expression levels in these areas peak at about 13.5 days of gestation, and decline thereafter. E2F-1 transcript levels become negligible throughout the 17.5 dpc brain, with the exception of the ventricular, proliferating areas of the cerebellum (Fig. 3D,E) . Thus, E2F-1 expression in the developing nervous system is maintained in the proliferating neuronal precursors, whereas growth arrest of these cells is accompanied by E2F-1 down-regulation.
E2F-1 transcripts in the 11.5-16.5 dpc spinal cord are scarce and uniformly distributed in the ventral and in the dorsal regions (data not shown).
E2F-2 and E2F-5 are first detected in the 9.5 dpc forebrain (Figs. 4A, 5A). By 10.5 dpc, E2F-2 is expressed broadly in the brain, and at lower levels in the upper regions of the spinal cord ( Fig. 4B ), whereas E2F-5 expression is very strong in the rostral, but not in the caudal regions of the spinal cord (Fig. 5B ). E2F-2 and E2F-5 are expressed throughout the developing central nervous system in 11.5 dpc embryos ( Fig. 4C and data not shown). In a pattern reminiscent of that described for E2F-1, E2F-2 and E2F-5 are broadly expressed in the undifferentiated ventricular Table 1 E2F and DP-I expression in developing neuronal tissues
Retina ( regions of the brain in 12.5-15.5 dpc embryos (Figs. 4D-G, X,D). E2F-2 and E2F-5 transcript levels peak at 12.5-13.5 days of gestation and are very low in 17.5-19.5 dpc brains (data not shdwn). In the developing spinal cord, E2F-2 transcripts are abundant in the dorsal, but not in the ventral region (Fig. 2F,G) . The dorsal mantle region of the spinal cord receives input from sensory neurons, whereas the ventral portion is involved in motor functions. Thus, E2F-2 may be important for the development and/or function of sensory neurons. E2F-2 and E2F-5 transcripts are barely detected in the peripheral nervous system, such as the dorsal root ganglia (Fig. 5C ,D and data not shown). The distribution patterns described for these E2F genes suggest that neuronal differentiation and migration out of the ventricular regions are accompanied by down-regulation of E2F-1, E2F-2 and E2F-5 expression. This down-regulation may be a prerequisite for neurons to exit the cell cycle.
In contrast to the elevated expression of E2F-1, EZF-2 and E2F-5 in the proliferating regions of the developing nervous system, E2F-3 transcript levels were low and localized to proliferating and non-proliferating areas throughout the brain (Fig. 6A ,B and data not shown). E2F-3 transcripts are more abundant in the spinal cord, both in the ventral and in the dorsal regions (Fig. 6C,D) . E2F-3 transcripts are also found in cranial and dorsal root ganglia in 14.5-18.5 dpc embryos (data not shown), a time when subs stantial differentiation has occurred in these regions. Simslarly, expression of E2F-4 and DP-1 is widespread in the 11.5-I 8.5 dpc central and peripheral nervous systems. The highest levels of E2F-4 and DP-1 were detected between 11.5 and 13.5 days of gestation. DP-1 transcripts are somewhat more abundant in ventricular areas throughout the developing brain ( Fig. 61-L) , whereas levels of E2F-4 expression were similar in ventricular, intermediate and marginal regions (Fig. 6E,F) . High E2F-4 transcript levels were also observed in the dorsal root ganglia (Fig. 6G,H) .
E2F expression in the developing neuronal retina
In the mouse, the neuronal retina develops from a single layer of undifferentiated retinoblasts first evident at about 10.5 dpc into a layered tissue containing various specialized cell types {reviewed in Saha et al., 1992) . These cells include the photoreceptor cells (rods and cones), the bodies of the ganglion cells, and the interneurons that transmit information from the rods and cones to the ganglion cells. There are also glial cells and amacrine neurons. The earliest differentiated retinal cells form the ganglion cell layer, which becomes morphologically distinct at approximately 14.5 dpc. The retinoblastic cell layer completes differentiation into the various cell types that constitute the retina about 1 week after birth.
E2F-1 expression in the developing retina is confined to the undifferentiated retinoblastic cell layer and is not detectable in the ganglion cell layer at any time (shown in 15.5 dpc retina in Fig. 7A,B) . During the first 2 days after birth, E2F-1 expression continues in the retinoblastic layer (Fig. 7C,D) , but 6 days after birth, when this layer is no longer apparent and has differentiated giving rise to the inner and outer nuclear layers, E2F-1 transcripts are no longer detected (Fig. 7E,F) . Similarly, E2F-2 and E2F-5 transcripts are very abundant in the 14.5-18.5 dpc embryonic retinoblastic cell layer, but are not detected in the differentiated ganglion cell layer (shown in 15.5 dpc retina in Fig. 7K,L) . These distribution patterns are reminiscent of those described above for the brain, where the proliferating undifferentiated ventricular zoqs express E2F-1, E2F-2 and E2F5. In contrast, E2F-3 transcript levels in embryonic retina are absent in the retinoblastic layer at all stages analyzed, and localize only to the ganglion cell layer (shown for 15.5 dpc retina in Fig. 7G,H) . We have yet to determine whether E2F-3 transcripts are expressed during the postnatal period in all layers of the fully differentiated retina.
E2F-4 transcripts were readily detected in both retinoblastic and ganglion cell layers between 12.5 and 18.5 days of gestqion (shown for 15.5 dpc retina in Fig. 71,J) . E2F-4 transcript levels do not change substantially with retinal diffqrqtiation, similar to E2F-4 levels in the central nervou$&%e&. DP-1 is expressed in both retinoblast and ganglioii:
layers from 14.5 days of gestation to 6 days after _* % ough higher transcript levels are apparent in the &&&&@ng cell layers than in the retinoblasts. DP-1 is expresse?l ifi all retinal layers in 6-day-old animals (data not shown).
E2F in non-neuronal brain cells: expression in choroid plexus
The choroid .plexus, the major site of synthesis of cerebrospinal fluid, is part of the blood brain barrier which separates the brain microenvironment from the blood plasma. It derives from the roof plate, and is formed by a single layer of neuroectodermal columnar epithelial cells that overlies a thick, highly vascularized mesenchymal layer. The anterior choroid plexus is situated in the lateral and third ventricles of the forebrain, whereas the posterior choroid plexus is found in the fourth ventricle of the hindbrain. The posterior choroid plexus is formed when the pseudostratified epithelium of a region in the roof of the fourth ventricle differentiates into a thin layer of columnar epithelium. In the mouse, the choroid plexus epithelium is first apparent at approximately' 12.5 days of gestation, by which time it is polarized and well differentiated both morphologically and functionally (Thomas et al., 1992; Thomas and Dziadek, 1993) .
In 13.5-18.5 dpc embryos, the anterior and posterior choroid plexus epithelia express high levels of E2F-4 and E2F-5 (shown in 13.5 dpc embryos in Fig. SC,D) . In contrast, E2F-2 transcript signals are barely above background (Fig. 8B) , and E2F-1 and EZF-3 transcripts are not detectable by in situ hybridization assays (data not shown). We have also noticed the absence of DP-1 transcripts in this 4 9.5 dpc 10.5 dpc 11.5 dpc 5 9.5 dpc 10.5 dpc tissue at all ages examined (Fig. 8E-G) . DP-1 transcripts are abundant throughout the mouse embryo and the choroid plexus may be one of the few tissues which does not express DP-1. Because functional E2F complexes consist of E2F/ DP heterodimers, choroid plexus may specifically express DP-2 or DP-3. Additional experiments are necessary to verify this hypothesis.
E2F expression in non-neuronal tissues
We have conducted an analysis of the expression of each E2F form and DP-1 during mouse embryogenesis in nonneuronal tissues to investigate if similar regulation at developmentally important stages occurs in other organs. The patterns of E2F expression in non-neuronal tissues are summarized in Table 2 . In intestinal and epidermal epithelia, E2F-2 and E2F-4 were expressed only in undifferentiated proliferating cells, whereas E2F-5 was expressed only in post-mitotic differentiating cells (Dagnino et al., 1997) .
In the thymus, very high DP-1, E2F-2 and E2F-4 transcript levels are present from 15.5 to 19.5 dpc. Of note is that in 19.5 dpc thymus, E2F-2 transcripts localize mainly to the cortical region which contains immature thymocytes. In contrast, very low levels of E2F-1 transcripts were detected in the thymus at all stages, and no E2F-5 and E2F-3 signals above background were observed (Table 2) .
In parenchymal organs including kidney, liver and lung, all five E2F forms and DP-1 are expressed from 13.5 to 19.5 days of gestation. The liver is one of the organs in which E2F-1, E2F-2 and E2F-4 mRNAs are most abundant. The pattern of E2F-1, E2F-4 and DP-1 expression throughout the liver is punctate, and transcripts are most abundant in cells with large cytoplasms morphologically identified as hepatocytes (Table 2 ). This agrees with previous reports that DP-1 and E2F-1 RNA levels are high in hepatocytes and low in hepatic hematopoietic foci (Tevosian et al., 1996) .
Expression of E2F in mesodermal tissues is also widespread. In cardiac muscle and tongue, transcripts of all five E2F forms and DP-1 are present from 11.5 to 19.5 dpc. In contrast, the only form readily detected in skeletal muscle during this time period is E2F-2 (Table 2 ). The developing vertebrae and ribs contained high levels of E2F-4 and DP-1 transcripts in the areas corresponding to the proliferating chondrocytes between 12.5 and 19.5 days of gestation. Low levels of E2F-2 and E2F-5 transcripts were observed in these regions, whereas no signal above background was evident for E2F-1 and E2F-3 (Table 2 ). It is noteworthy that E2F transcripts are not expressed in the osteoblasts within the limits of sensitivity of the in situ hybridization technique.
Discussion
Given the importance of the E2F family of transcription factors in controlling cell proliferation, we examined the expression of these genes throughout mouse embryogenesis, especially in tissues undergoing rapid expansion, such as the nervous system. Our study demonstrates widespread expression of E2F factors during mouse organogenesis.
The expression of E2F in tissues of all embryonic origins suggests a central role for these transcription factors in mammalian development. The expression patterns of each E2F form depend on the tissue, suggesting that a given E2F may fulfill different functions in different cell types and/or developmental stages. This idea is consistent with the observed multiplicity of functions identified for E2F-1 in other systems. Indeed, E2F-1 appears to be involved in cell proliferation and oncogenesis in apoptosis and in tumor suppression (Nevins, 1992; Johnson et al., 1994a; Shan and Lee, 1994; Singh et al., 1994; Wu and Levine, 1994; Jooss et al., 1995; Yang and Sladek, 1995; Field et al., 1996; Yamasaki et al., 1996) . Multiple mechanisms are likely to regulate E2F activity itself. Although post-transcriptional modifications such as phosphorylation and association with pRB proteins are important, regulation of transcript Fig. 3 . Expression of E2F-1 in the developing nervous system. Bright-field (A,D) and corresponding dark-ground (B,E) micrographs of embryo sections of the indicated gestational ages hybridized to the E2F-1 probe. E2F-1 is detected in the 9.5 dpc neural tube (A,B), and in the ventricular layer of the 17.5 dpc cerebellum, shown here in a coronal section (D,E). (C) depicts a frontal and a lateral view of 10.5 dpc embryos in whole-mount in situ hybridization experiments with the same E2F-1 probe. Hybridization is observed in the developing forebrain, midbrain and hindbrain. The asterisk indicates the boundary of E2F-1 expression in the spinal cord. c, cerebellum; f. forebrain; h, hindbrain; m, midbrain; nt, neural tube; vl, ventricular layer. Hybridization of the E2F-5 probe to 13.5 dpc sagittal embryo sections is shown in the micrographs in (C) (bright-field) and (D) (corresponding darkground). de, diencephalon; dg, dorsal root ganglia; f, forebrain; fv, fourth ventricle; h, hindbrain; mb, midbrain: te, telencephalon.
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DPl Fig. 6 . Expression of E2F-3, E2F-4 and DP-1 in the nervous system. Bright-field (A,C,E,G,I,K) and corresponding dark-ground (B,D,F,H,J,L) micrographs of sagittal embryo sections hybridized with the indicated antisense probe. E2F-3 expression is shown in 13.5 dpc pons (A,B) and 15.5 dpc spinal cord (C,D). E2F-4 expression is shown in 13.5 thalamus and brain (E,F) and 15.5 dorsal root ganglia (G,H). DP-1 signals are shown in the 13.5 dpc pons (I,J), and throughout the brain in the 11.5 dpc embryo (K,L). de, diencephalon; dg, dorsal root ganglia; fv, fourth ventricle; mb, midbrain; ml, mantle layer; p, pons; t, thalamus; te, telencephalon; v, vertebrae. levels also occurs in a variety of tissues (this study and Dagnino et al., 1997) . Our observations that tissues that express E2F-1 also express high transcript levels of other E2F forms suggest that the normal development observed in E2F-l-/-mice (Field et al., 1996; Yamasaki et al., 1996) may be due to phenotypic redundance or compensation of E2F-1 function by other E2F forms.
DifSerential expression of E2F factors during neuronal development
E2F-1, E2F-2 and E2F-5 are first detected in the developing nervous system in the 9.5 dpc forebrain. The regions of expression of these genes expand caudally as development continues up to 11.5 dpc. The onset of E2F expression occurs at a stage when patterning is established in these regions (Simeone et al., 1992a; Simeone et al., 1992b; Simeone et al., 1993) . E2F expression may be induced as neuronal precursors reach a certain stage of development, although additional studies with specific markers are necessary to establish the precise relationship between onset of E2F expression and nervous system patterning. Later during gestation, E2F-1, E2F-2 and E2F-5 are expressed in highly proliferative areas throughout the nervous system. These E2F forms may function to maintain proliferation of neuronal precursors. This conclusion is also supported by the marked reduction in E2F-1, E2F-2 and E2F-5 transcript levels in the brains of late-gestation embryos, when the proportion of post-mitotic cells is greater. E2F-2 is present in proliferating cells of various tissues, including thymocytes, hematopoietic cells in the fetal liver, as well as the basal cells in the epidermis and the intestinal intervillum epithelium (Dagnino et al., 1997) . Thus, E2F-2 may be required to maintain or promote cell proliferation in a variety of tissues.
The down-regulation of E2F-5 expression in differentiating neuronal cells contrasts sharply to changes in E2F-5 transcript levels observed in differentiating epithelial cell types. Indeed, E2F-5 transcripts are not detected in the actively proliferating regions of the epidermis and the intestinal epithelium, whereas they are very abundant in the post-mitotic suprabasal epidermal layers and upper regions of the developing intestinal villi (Dagnino et al., 1997) . These observations confirm the idea that a given E2F form probably fulfills different functions and is subjected to non-identical regulation mechanisms in different tissues.
The activity of E2F is also regulated by its association with the pRB family of proteins. The expression of pRB and ~130 in the nervous system includes ventricular and marginal regions, whereas ~107 expression is limited to the ventricular zone (Jiang et al., 1997) . These distribution patterns suggest that in proliferating undifferentiated neuronal cells, progression through the cell cycle may be regulated by the interactions of pRB with E2F-1 or E2F-2, on the one hand, and those of ~107 and/or ~130 with E2F-4 and E2F-5 on the other hand. In differentiating retinal neurons E2F-3 may be expressed, and by associating with pRB it may down-regulate transcription of E2F-1, E2F-2 and/or E2F-5. Both E2F-1 and E2F-2 have functionally important E2F sites in their promoters (Hsiao et al., 1994; Johnson et al., 1994b; Sears and Nevins, 1995) . Down-regulation of E2F-1, E2F-2 and E2F-5 could, in turn, extinguish the expression of genes necessary for progression through the 15.5 dpc Fig. 7 . E2F in the developing retina. Bright-field (A,C,E,G,I,K) and corresponding dark-ground micrographs (B,D,F,H,J.L) of eye sections hybridized to the indicated probe. E2F-1 transcripts are detected in the retinoblast cell layer in 15.5 dpc retina (A,B), and in the retinoblastic layer of 2-day-old pups (CD). No E2F-1 transcripts are evident in retina from 6-day-old pups (E,F). In contrast, E2F-3 expression is confined to the ganglion cell layer in 15.5 dpc retina (G,H), whereas E2F-4 is expressed in retinoblast and ganglion cell layers in 15.5 dpc embryos (1.J). At this stage, E2F-5 expression is high in the undifferentiated retinoblast layer (K,L). g, ganglion cell layer: nl, inner and outer nuclear layers; r, retinoblast cell layer. S phase. The observed variation in E2F transcript levels may also be due to differences in mRNA stability, and further studies are necessary to determine the relative contribution to steady-state transcript levels of transcription rate and transcript stability.
Role of E2F in liver, lung and kidney development
In contrast to the observed changes in E2F RNA levels in nervous tissue, no variation in E2F transcript levels was evident in parenchymal organs such as liver, lung and kidney. Because proliferating undifferentiated cells and postmitotic terminally differentiated cells do not occupy separate regions in these organs, it is possible that changes in E2F transcript levels are masked by this developmental heterogeneity. Alternatively, E2F activity in lung and kidney may be regulated mainly via post-transcriptional mechanisms. Additional experiments are necessary to clarify this issue. Whereas all E2F and pRB family members are expressed in the liver, only ~107 has been detected in lung and kidney (Jiang et al., 1997) . It remains to be established in these organs which pRb-family members, if any, regulate the activity of E2F-1, E2F-2 andE2F-3.
Correlation between E2F expression and developmental abnormalities in RB-'-and RB-'-:plO7-'-embryos
The developmental abnormalities described in RB-/-embryos include ectopic mitoses and increased apoptosis in the nervous system, as well as abnormal livers (Clarke et al., 1992; . Ectopic expression of E2F-1 has been shown to trigger apoptosis in a p53-dependent manner (Qin et al., 1994; Wu and Levine, 1994; Hiebert et al., 1995; Kowalik et al., 1995) . Thus, increased apoptosis in the nervous system of RB-/-animals may arise from dysregulation of E2F-1 and/or E2F-2 activity. A role for Table 2 E2F and DP-1 expression in non-neuronal tissues during mouse embryogenesis E2F-4 and/or E2F-5 in this process is also suggested by the observation that defects in neurogenesis are exacerbated by the lack of ~107 in RB-'-:plO7-/-double mutant mice (Lee et al., 1996) . It remains to be determined whether E2F-1, E2F-2 and E2F-5 expression is down-regulated in differ-
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Mutant RB-/-embryos also have decreased hepatocyte numbers and defective liver erythropoiesis.
RB" erythroid precursors do not reach end-stage differentiation in vivo or in culture (Clarke et al., 1992; . However, it has not been determined whether a defective hepatic microenvironment also contributes to this detect. In the liver, differences in the distribution of various E2F forms were evident. Hepatocytes expressed high E2F-1 transcript levels, as reported elsewhere (Tevosian et al., 1996) . In contrast, E2F-2 transcripts were very abundant in hematopoietic islands, which contain many mitotically active cells, but were not detected in large hepatocytes. Substantial levels of E2F-4 transcripts were also observed in the embryonic liver at all developmental stages examined. The absence of pRB may lead to dysregulation of E2F-1 and E2F-2 activity, followed by apoptosis, in a manner similar to that described for the nervous system. The exacerbation of apoptosis in the liver of RB-'-:pl07-'-double mutant mice suggests that dysregulation of E2F-4 may also contribute to cell death and/or that ~107 can regulate E2F-1 and E2F-2 function to some degree.
DNA sequencing and sequence analysis
Double-strand DNA sequencing of mouse E2F-3 cDNA fragments was performed by the dideoxynucleotide chain termination method using Sequenase 2.0 (USB) and the PrismTM Ready Reaction DyeDeoxyTM Terminator Cycle Sequencing Kit (Perkin Elmer). Both strands of each cDNA fragment were sequenced. DNA and translated amino acid sequences were analyzed using the University of Wisconsin Genetics Computer Group software package.
RNA analysis
The developmental defects observed in mice carrying mutations in pRB-, p107-and pl30-encoding genes generally involve increased proliferation of affected tissues without general impairment of terminal differentiation processes. An important function of these proteins is regulation of E2F activity, suggesting that during development a function of E2F may be modulation of cell proliferation. Thus, during certain developmental stages, cells may use E2F to promote proliferation. Once differentiation signals are received, the role of E2F factors may be inhibition of proliferation, by virtue of their association with pRB family members. This implies that regulation of E2F activity may be necessary to coordinate processes leading to cessation of proliferation with those involved in expression of differentiation genes.
Total RNA from tissues or cultured cells was isolated using guanidinium thiocyanate (Chomczynski and Sacchi, 1987) . Poly(A)+ RNA was then isolated by purification on Oligotex beads (Qiagen), quantified spectrophotometrically and 5-8 pg were fractionated on 1.2% agarose gels containing 1% formaldehyde. The RNA was blotted onto Hybond-N membranes (Amersham) and the blots were hybridized to the indicated cDNA probes. The probes were labeled by random-priming using [a-32P]dATP and [a-32P]dCTP. Hybridization was conducted for 20 h in 25 mM potassium phosphate (pH 7.4), 5x SSC, 5x Denhardt's solution, 50% formamide and 50 mg/ml sonicated salmon sperm DNA. Blots were washed twice at 25°C with 0.1x SSC/O.l% SDS for 15 min, and then once at 55°C for 25 min. Differences in loading were corrected by normalizing to the signal obtained from cyclophilin (Danielson et al., 1988) .
Plasmids
Experimental procedures
The cDNA probes used in this study were pAltermE2F-1, mE2F-2-D2, mE2F-4-Xba, mEZF-4-Pst and SK-mE2F-5, which have been described (Dagnino et al., 1997) and are schematically shown in Fig. 2 . The mouse E2F-3 probe contains a 397-bp fragment of the clone mE2F3Cl from positions 1456 to 1853 cloned in pBSM13+ (Fig. 1 ). These sequences correspond to the 3'-untranslated region of the mouse E2F-3 cDNA. 4.1. Library screening and cloning of mE2F3 cDNA fragments 4.5. In situ hybridization
Mouse E2F-3 sequences were isolated from a 3T3 fibroblast hgtll cDNA library as described (Li et al., 1994) . A human E2F-3 cDNA probe containing sequences from nucleotides 730 to 1479 (gift from J. Lees) was used to screen 3.5 x lo5 plaques. Three partial mouse E2F-3 cDNA fragments were obtained and cloned into the EcoRI site of pBSMlS+ (Stratagene) to create mE2F-3C1, mE2F-3B1 and mE2F-3G2 (Fig. 1) . Partial sequencing indicated that these three cDNA fragments overlap and together contain mouse E2F-3 cDNA sequences from positions 328 to In situ hybridization experiments were conducted using 8-pm paraffin or frozen sections from developmentallystaged C.B-17 embryos. Midday of the time of appearance of vaginal plugs was considered as 0.5 dpc to time pregnancies. For paraffin sections, embryos were fixed overnight in 4% pamformaldehyde, dehydrated in ethanol and embedded in paraffin. For cryosections, embryos were protected by embedding in OCT compound (Miles) prior to freezing. Pretreatments of frozen sections included fixing in 4% paraformaldehyde for 1 h, followed by proteinase K digestion (20 pg/ml, 7.5 min, 25°C) and acetylation (0.1 M triethanolamine (pH 8.0), 0.25% acetic anhydride, 10 min, 25°C). Subsequently, the sections were dehydrated with ethanol and air-dried prior to the addition of hybridization solution. Pretreatment of paraffin sections and hybridization to [a33P]UTP-labeled sense and antisense probes (15 OOO-40000 cpm/pl) were conducted as described (Dagnino et al., 1997) . Slides were exposed to emulsion for l-3 weeks prior to development, after which were stained lightly with hematoxylin and eosin. Whole-mount in situ hybridization was conducted with digoxigenin-labeled probes as described by Hui and Joyner, 1993. 
